Skip to main content
NCBI home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1991 Jan;33(1):1–8. doi: 10.1007/BF01742520

Potentiation of delayed-type hypersensitivity response to syngeneic tumors in mice prevaccinated with cells modified by hydrostatic pressure and crosslinking

Venkatesh Ramakrishna 1, Meir Shinitzky 1,✉
PMCID: PMC11038986  PMID: 2021954

Abstract

Delayed-type hypersensitivity (DTH) to the chemically induced EL4 and virally induced ARadLV 136 leukemia cells was determined by the radioactive ear test. Prior to the DTH test, mice were prevaccinated with cells treated either with hydrostatic pressure or with the membrane-impermeant crosslinker adenosine dialdehyde or with a combination of these. For both tumor cells, DTH against unmodified cells was markedly potentiated by prevaccination with cells treated with hydrostatic pressure combined with adenosine dialdehyde. In vitro cytotoxicity data indicated that maximal lysis of target cells is induced by vaccination with adenosine-dialdehyde-treated cells, as well as by pressure in combination with adenosine dialdehyde treatment. In addition, increased [3H]thymidine uptake was observed in effector T cells induced by prevaccination with tumor cells modified by adenosine dialdehyde or pressure or both. This novel and innocuous potentiation of an antitumor immune response may have a practical utility in the treatment of human cancer.

Key words: Tumor antigens, Hydrostatic pressure, Crosslinking, DTH

References

  • 1.Brunner TK, Engers HD, Cerottini JC. The51Cr release assay as used for the quantitative measurement of cell-mediated cytolysis in vitro. In: Bloom BR, David JR, editors. In vitro methods in cell-mediated and tumor immunity. London: Academic Press; 1976. p. 423. [Google Scholar]
  • 2.Crowle AJ. Delayed hypersensitivity in the mouse. Adv Immunol. 1975;20:197. doi: 10.1016/s0065-2776(08)60209-6. [DOI] [PubMed] [Google Scholar]
  • 3.Deckmann M, Haimovitz R, Shinitzky M. Selective release of integral proteins from human erythrocyte membranes by hydrostatic pressure. Biochim Biophys Acta. 1985;821:334. doi: 10.1016/0005-2736(85)90103-8. [DOI] [PubMed] [Google Scholar]
  • 4.Gorer PA. The isoantigens of malignant cells. In: Harris RJC, editor. Biological approaches to cancer chemotherapy. New York: Academic Press; 1961. p. 219. [Google Scholar]
  • 5.Hansske F, Sprinzl M, Cramer F. Reaction of the ribose moiety of adenosine and AMP with periodate and carboxylic acid hydrazides. Bioorg Chem. 1974;3:367. [Google Scholar]
  • 6.Haran-Ghera N, Ben-Yorakov M, Peled A. Immunological characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants: I. Cellular analysis of immunosuppression. J Immunol. 1977;118:600. [PubMed] [Google Scholar]
  • 7.Hawrylko E. Induction of delayed-type hypersensitivity and anti-tumor immunity by systemic BCG. Cell Immunol. 1980;50:136. doi: 10.1016/0008-8749(80)90013-1. [DOI] [PubMed] [Google Scholar]
  • 8.Hoover HC, Surdyke M, Dargel RB, Peters LC, Hanna MG. Delayed cutaneous hypersensitivity to autologous tumor cells in colorectal cancer patients immunized with an autologous tumor cell: bacillus Calmette-Guérin vaccine. Cancer Res. 1984;44:1671. [PubMed] [Google Scholar]
  • 9.Knulst AC, Berends D, Bazuin C, van Rooij HCJ, de Both NJ, Benner R. Enhancement and suppression of DTH reactivity to Rauscher murine leukaemia virus induced tumor cell lines. Br J Cancer. 1989;60:351. doi: 10.1038/bjc.1989.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.LeFever AV, Killion JJ, Kollmorgen GM. Active immunotherapy of L1210 leukemia with neuraminidase-treated drugresistant L1210 sublines. Cancer Immunol Immunother. 1976;1:211. [Google Scholar]
  • 11.Lider O, Shinitzky M, Cohen IR. Vaccination against experimental autoimmune diseases using T-lymphocytes treated with hydrostatic pressure. Proc NY Acad Sci. 1986;275:267. doi: 10.1111/j.1749-6632.1986.tb20875.x. [DOI] [PubMed] [Google Scholar]
  • 12.Lider O, Karin N, Shinitzky M, Cohen IR. Therapeutic vaccination against adjuvant arthritis using autoimmune T-cells treated with hydrostatic pressure. Proc Natl Acad Sci USA. 1988;84:4577. doi: 10.1073/pnas.84.13.4577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Muller CP, Shinitzky M. Passive shedding of erythrocyte antigens induced by membrane rigidification. Exp Cell Res. 1981;136:53. doi: 10.1016/0014-4827(81)90037-9. [DOI] [PubMed] [Google Scholar]
  • 14.North RJ, Awwad M, Dunn PL, et al. T cell-mediated tumor regression in experimental systems. In: Melchers F, et al., editors. Progress in immunology — Proceedings of the 7th International Congress of Immunology, Berlin 1989, vol 7. Berlin, Heidelberg, New York: Springer-Verlag; 1989. p. 1097. [Google Scholar]
  • 15.Old LJ, et al. Structural basis for tumor cell recognition by the immune system. In: Melchers F, et al., editors. Progress in immunology — Proceedings of the 7th International Congress of Immunology, Berlin 1989, vol 7. Berlin, Heidelberg, New York: Springer-Verlag; 1989. p. 1053. [Google Scholar]
  • 16.Prager MD, Baechtel SF. Methods for modification of cancer cells to enhance their antigenicity. Methods Cancer Res. 1973;9:339. [Google Scholar]
  • 17.Richert L, Or A, Shinitzky M. Promotion of tumor antigenicity in EL4 leukemia cells by hydrostatic pressure. Cancer Immunol Immunother. 1986;22:119. doi: 10.1007/BF00199125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rios A, Simmons RL. Immunospecific regression of various syngeneic mouse tumors in response to neuraminidase-treated tumor cells. J Natl Cancer Inst. 1973;51:637. [PubMed] [Google Scholar]
  • 19.Sedlacek HH, Bengelsdorff KH, Hagmayer G, Seiler FR. Tumor therapy of neoplastic disease with tumor cells and neuraminidase: experimental studies on chessboard vaccination in transplantation tumors. Int J Immunopharmacol. 1987;9:841. doi: 10.1016/0192-0561(87)90081-6. [DOI] [PubMed] [Google Scholar]
  • 20.Shinitzky M, Skornick Y. Cancer immunotherapy with autogtlogous and allogeneic vaccines: a practical overview. Prog Clin Biol Res. 1990;348:95. [PubMed] [Google Scholar]
  • 21.Shinitzky M, Souroujon M. Passive modulation of bloodgroup antigens. Proc Natl Acad Sci USA. 1979;76:4438. doi: 10.1073/pnas.76.9.4438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Skornick Y, Danciger E, Rozin RR, Shinitzky M. Positive skin tests with autologous tumor cells of increased membrane viscosity: first report. Cancer Immunol Immunother. 1981;11:93. [Google Scholar]
  • 23.Skornick Y, Dresdale AR, Sindelar WF. Induction of delayed hypersensitivity reactions in cancer patients by cholesteryl hemisuccinate-treated autologous tumor cells. J Natl Cancer Inst. 1983;70:465. [PubMed] [Google Scholar]
  • 24.Skornick Y, Gorelik E, Klausner J, Shinitzky M, Sindelar WF. Inhibition of growth and metastases in mice by immunization with cholesteryl hemisuccinate-enriched tumor cells. Cancer Lett. 1984;25:153. doi: 10.1016/s0304-3835(84)80040-3. [DOI] [PubMed] [Google Scholar]
  • 25.Skornick YG, Rong GH, Sindelar WF, Richert L, Klausner JM, Rozin RR, Shinitzky M. Active immunotherapy of human solid tumor with autologous cells treated with cholesteryl hemisuccinate — a phase I study. Cancer. 1986;58:650. doi: 10.1002/1097-0142(19860801)58:3<650::aid-cncr2820580309>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  • 26.Suda T, Fujiwara H, Mizushima Y, Shearer GM, Hamaoka T. Augmentation of anti-tumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2− T-cell mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers. J Natl Cancer Inst. 1986;77:1267. [PubMed] [Google Scholar]
  • 27.Tanake K, Hayashi H, Hamada C, Khoury G, Jay G. Expression of major histocompatibility complex class I antigens as a strategy for the potentiation of immune recognition of tumor cells. Proc Natl Acad Sci USA. 1986;83:8723. doi: 10.1073/pnas.83.22.8723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Vadas MA, Miller JFAP, Gamble J, Whitelaw A. A radioisotopic method to measure delayed-type hypersensitivity in the mouse: I. Studies in the sensitized and normal mice. Int Arch Allergy Appl Immunol. 1975;49:670. doi: 10.1159/000231449. [DOI] [PubMed] [Google Scholar]
  • 29.Vánky F, Stjernswärd J. Lymphocyte stimulation test for detection of tumor-specific reactivity in humans. In: Bloom BR, David JR, editors. In vitro methods in cell-mediated and tumor immunity. New York: Academic Press; 1976. p. 597. [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES